Connection

Michael Hallek to Mitoxantrone

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Mitoxantrone.
Michael Hallek
Connection Strength
0.049
Mitoxantrone
  1. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leuk Lymphoma. 2019 03; 60(3):649-657.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.